Disclosure Standard, and sesame allergen labeling, have imposed billions of dollars of costs on the food supply, ultimately increasing consumer food costs. The purported benefits of those requirements were speculative and based on limited evidence.
The ABA recommends that the FDA undertake a retrospective analysis of the projected costs and benefits of the 2016 rule requiring revisions to the Nutrition Facts Label. Such an analysis would inform the projection of the costs and benefits of a requirement for an FOP nutrition labeling scheme.
The ABA has also asked the FDA to consider whether the Agency has the authority to require FOP nutrition labeling, given that the Food, Drug, and Cosmetic Act (FDCA) does not expressly authorize such a requirement.
IFAC and its members are awaiting the FDA's proposed rule on front-of-package (FOP) nutrition labeling and intend to engage with our industry partners once it is issued. “We encourage the FDA to ensure that any labeling is accurate, based on scientific evidence, and would reduce potential consumer confusion.”